{"id":"dymista-nasal-spray","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Epistaxis (nosebleed)"},{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Dysgeusia (taste disturbance)"},{"rate":null,"effect":"Somnolence"}]},"_chembl":{"chemblId":"CHEMBL14012","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azelastine blocks histamine H1 receptors to provide rapid symptom relief from itching, sneezing, and rhinorrhea, while fluticasone propionate reduces nasal inflammation and mucus production through glucocorticoid receptor activation. The combination provides both immediate antihistamine relief and sustained anti-inflammatory control of allergic rhinitis.","oneSentence":"DYMISTA is a nasal spray combining azelastine (a selective H1-receptor antagonist) and fluticasone propionate (a corticosteroid) to reduce allergic rhinitis symptoms through dual anti-inflammatory and antihistamine action.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:10:23.674Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis (seasonal and perennial)"}]},"trialDetails":[{"nctId":"NCT02402465","phase":"PHASE4","title":"Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02","conditions":"Allergic Rhinitis","enrollment":22},{"nctId":"NCT05146206","phase":"","title":"Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray","status":"COMPLETED","sponsor":"Community and Patient Preference Research Pty Ltd","startDate":"2021-11-08","conditions":"Allergic Rhinitis","enrollment":426},{"nctId":"NCT06180083","phase":"PHASE1","title":"Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2023-03-24","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":56},{"nctId":"NCT05158972","phase":"","title":"Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2021-10-27","conditions":"Allergic Rhinitis","enrollment":924},{"nctId":"NCT04601324","phase":"PHASE4","title":"Allergic Rhinitis Combination Pharmacotherapy Efficacy Study","status":"WITHDRAWN","sponsor":"St. Paul's Sinus Centre","startDate":"2020-12-15","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT06051786","phase":"PHASE2","title":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Synmosa Biopharma Corp.","startDate":"2020-08-20","conditions":"Allergic Rhinitis","enrollment":136},{"nctId":"NCT04652245","phase":"PHASE4","title":"Dymista Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2020-12-14","conditions":"Seasonal Allergic Rhinitis","enrollment":216},{"nctId":"NCT03599791","phase":"PHASE3","title":"DYmista NAsal Spray in CHInese Patients","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2018-06-29","conditions":"Allergic Rhinitis","enrollment":900},{"nctId":"NCT03004131","phase":"PHASE4","title":"MP-AzeFlu Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2017-01-07","conditions":"Seasonal Allergic Rhinitis","enrollment":82},{"nctId":"NCT01190852","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT01194622","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT02953106","phase":"PHASE4","title":"Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis","status":"TERMINATED","sponsor":"University of Dundee","startDate":"2017-01-20","conditions":"Asthma, Allergic, Rhinitis,Allergic, Allergy","enrollment":7},{"nctId":"NCT03444506","phase":"PHASE2","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-01-27","conditions":"Seasonal Allergic Rhinitis","enrollment":180},{"nctId":"NCT02238353","phase":"PHASE4","title":"AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)","status":"UNKNOWN","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-10","conditions":"Allergic Rhinitis, House Dust Mite Allergy","enrollment":45},{"nctId":"NCT01915823","phase":"PHASE3","title":"Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2013-07","conditions":"Seasonal Allergic Rhinitis","enrollment":348},{"nctId":"NCT01794741","phase":"PHASE3","title":"3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2013-02","conditions":"Allergic Rhinitis","enrollment":405},{"nctId":"NCT02279563","phase":"PHASE2","title":"A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Apotex Inc.","startDate":"2013-12","conditions":"Seasonal Allergic Rhinitis","enrollment":595},{"nctId":"NCT02249663","phase":"PHASE3","title":"Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™","status":"UNKNOWN","sponsor":"Teva Pharmaceuticals USA","startDate":"2014-08","conditions":"Seasonal Allergic Rhinitis","enrollment":1535},{"nctId":"NCT00845598","phase":"PHASE4","title":"Azelastine Fluticasone Combination vs. Fluticasone","status":"WITHDRAWN","sponsor":"University of Dundee","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":494,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"DYMISTA nasal spray","genericName":"DYMISTA nasal spray","companyName":"Glenmark Pharmaceuticals Ltd. India","companyId":"glenmark-pharmaceuticals-ltd-india","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DYMISTA is a nasal spray combining azelastine (a selective H1-receptor antagonist) and fluticasone propionate (a corticosteroid) to reduce allergic rhinitis symptoms through dual anti-inflammatory and antihistamine action. Used for Allergic rhinitis (seasonal and perennial).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}